NIH-funded research U01 cooperative agreement

Frequent Exacerbator Pediatric Asthma: A Multi-Omics Approach

Official title: Multi-omics of the Frequent Exacerbator Asthmatic

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11598481 · Data updated 2026-11-12

A pediatric multi-omics study aims to understand why some children with asthma have more frequent flare-ups and how that affects their health and care.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startApril 9, 2021
Project endMarch 31, 2028
Funding year2026
Award (this year)$328,646
NIH project number3U01AI159087-06S1
Project IDNIH-11598481 on NIH RePORTER

Who could benefit from this research

Could help

Children and youths with asthma (including those from urban, low-income backgrounds) who experience frequent exacerbations may be eligible.

Less likely to help

Children with well-controlled asthma and infrequent exacerbations may have less direct benefit from this specific study.

What this research studies

This project focuses on children with asthma who experience two or more exacerbations per year and uses advanced omics methods to uncover biological and clinical factors associated with these frequent flares. Researchers will collect and integrate biological samples, clinical data, and environmental information to identify patterns linked to increased risk. The goal is to inform better risk stratification, personalized management, and targeted interventions for high-risk pediatric patients in urban settings. Parents and caregivers may be engaged to support study activities and help translate findings into real-world care improvements.

Why it matters

Potential benefit: This research could lead to earlier identification of high-risk children and more effective, personalized treatments to reduce asthma flare-ups and healthcare costs.

How similar studies have gone: Prior studies have begun to identify phenotypes related to frequent exacerbations, but this project aims to deepen understanding with a multi-omics approach.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Khurana Hershey, Gurjit K. — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Khurana Hershey, Gurjit K.

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.